Stroke Research and Treatment / 2017 / Article / Tab 3

Research Article

Serum Uric Acid Is Associated with Poor Outcome in Black Africans in the Acute Phase of Stroke

Table 3

Independent predictors of death within 3 months after stroke.

PredictorsAliveDiedUnadjusted OR (95% CI) valueAdjusted OR (95% CI) value

Age > 45 years306 (63.9)173 (18.9)1.527 (0.842.635)0.1270.984 (0.451–2.147)0.967
Male gender206 (66.7)103 (33.3)0.856 (0.602–1.216)0.384
HTN343 (65.1)184 (34.9)1.013 (0.443–2.318)0.975
DM111 (57.2)83 (42.8)1.693 (1.1782.432)0.0040.984 (0.506–1.913)0.961
Smoking70 (76.7)21 (23.1)0.506 (0.3000.853)0.0100.839 (0.372–1.895)0.673
Alcohol151 (70.9)62 (29.1)0.665 (0.454–0.946)0.0240.768 (0.417–1.412)0.395
Dyslipidemia285 (68.8)129 (31.2)0.530 (0.358–0.786)0.0010.602 (0.305–1.187)0.143
Obesity113 (71.1)46 (28.9)0.684 (0.459–1.019)0.0610.429 (0.103–1.778)0.243
METS93 (69.9)40 (30.1)0.751 (0.4921.143)0.1801.705 (0.359–8.103)0.502
CAD/IHD23 (67.6)11 (32.4)0885 (0.422–1.858)0.748
AFIB34 (49.3)35 (50.7)2.124 (1.2753.533)0.0033.198 (1.3867.376)0.006
Cardiopathy36 (52.9)32 (47.1)1.789 (1.0722.986)0.0251.129 (0.483–2.642)0.779
Valvulopathy20 (66.7)10 (33.3)0.929 (0.426–2.027)0.853
Previous stroke71 (62.3)43 (37.7)1.167 (0.761–1.788)0.479
CKD17 (43.7)22 (56.4)2.596 (1.3435.017)0.0032.139 (0.829–5.522)0.116
Hemorrhagic stroke104 (53.1)92 (46.9)2.242(1.5603.223)<0.0011.211 (0.635–2.307)0.561
SBP > 140 mmHg276 (63.6)158 (36.4)1.574 (0.8852.134)0.1561.751 (0.803–3.821)0.159
DBP > 90 mmHg227 (62.4)137 (37.6)1.867 (1.2252.854)0.0610.801 (0.405–1.586)0.525
Hyperglycemia107 (52.2)98 (47.8)2.439 (1.6993.502)<0.0012.263 (1.2034.256)0.011
High LDLc270 (66.0)139 (34.0)0.858 (0.578–1.273)0.447
Low HDLc210 (70.9)86 (24.7)0.574 (0.4030.817)0.0020.673 (0.394–1.148)0.146
High TC170 (62.7)101 (37.3)1.227 (0.865–1.741)0.252
High TG70 (51.1)67 (48.9)2.203 (1.4843.270)<0.0011.857 (1.0033.437)0.049
Hyperuricemia148 (56.5)114 (40.7)2.067 (1.4492.950)<0.0011.265 (0.707–2.263)0.428
GCS ≤ 88 (8.7)84 (91.3)33.908(15.91672.242)<0.0017.604 (3.22117.948)<0.001
NIHSS > 1460 (27.6)157 (72.4)21.806(13.82034.407)<0.0016.733 (3.65912.390)<0.001
mRS > 2184 (50.0)184 (50.0)19.556(9.70839.392)<0.0013.363 (1.4567.767)0.005
Complications108 (46.6)124 (53.4)4.193 (2.8946.075)<0.0011.631 (0.943–2.821)0.080

METS: metabolic syndrome; AFIB: atrial fibrillation; CKD: chronic kidney disease; CAD/IHD: coronary artery/ischemic heart disease.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.